Phase II Study of Itraconazole and Pemetrexed in Patients With Previously Treated Non-Squamous NSCLC
Stopped Low accrual.
Conditions
- Recurrent Non Small Cell Lung Cancer
Interventions
- DRUG: Itraconazole
- DRUG: Pemetrexed
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins